BVF PARTNERS L P/IL

Average Profitability
3.86%
Insider Buys Quantity
174
Insider Buys Sum
$401.08M
Insider Sells Quantity
52
Insider Sells Sum
$253.38M

Insider Activity of BVF PARTNERS L P/IL

According to the SEC Form 4 filings, BVF PARTNERS L P/IL, being in a position of

  1. 10 percent owner at Eledon Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 1927937 shares for $4.57M, and sold 0 shares,
    over all time since 2023-05-05, has bought 3906869 shares for $9.14M, and sold 0 shares.

The largest purchase of all time was on 2021-07-01 and amounted to 1088332 shares of Kymera Therapeutics, Inc. for $51.15M.

The largest sale of all time was on 2021-07-02 and amounted to 2186022 shares of Merus N.V. for $45.36M.

Biography of BVF PARTNERS L P/IL

No biography is available at this moment.

2024-05-09PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1.93M
7.8677%
$2.37$4.57M+15.4%
2023-11-16PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
295,745
0.6815%
$5.38$1.59M-29.73%
2023-11-15PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
931,556
2.0265%
$5.00$4.66M-28.57%
2023-11-03PurchaseKymera Therapeutics, Inc.
KYMR
director
197,699
0.3518%
$14.07$2.78M+153.89%
2023-11-02PurchaseKymera Therapeutics, Inc.
KYMR
director
216,406
0.3771%
$11.64$2.52M+199.01%
2023-11-02PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
783,709
1.8363%
$3.60$2.82M+8.01%
2023-09-12PurchaseOlema Pharmaceuticals, Inc.
OLMA
1.51M
2.9937%
$9.84$14.82M+1.67%
2023-05-05PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1.98M
11.9399%
$2.31$4.57M-41.42%
2023-01-12PurchaseKymera Therapeutics, Inc.
KYMR
director
18,897
0.0302%
$31.24$590,391-26.07%
2023-01-11PurchaseKymera Therapeutics, Inc.
KYMR
director
22,110
0.038%
$29.89$660,799-16.97%
2023-01-06PurchaseXOMA Corporation
XOMA
director
1,573
0.0137%
$21.98$34,577-19.69%
2023-01-06PurchaseXOMA Corporation
XOMA
director
3,249
0.0282%
$21.98$71,419-19.69%
2023-01-05PurchaseXOMA Corporation
XOMA
director
15,670
0.1152%
$18.39$288,096-18.64%
2023-01-05PurchaseXOMA Corporation
XOMA
director
19,000
0.1396%
$18.39$349,319-18.64%
2022-01-31PurchaseKymera Therapeutics, Inc.
KYMR
director
34,408
0.0646%
$40.70$1.4M-33.05%
2022-01-27PurchaseKymera Therapeutics, Inc.
KYMR
director
95,901
0.1917%
$38.33$3.68M-24.25%
2022-01-24PurchaseKymera Therapeutics, Inc.
KYMR
director
272,767
0.4999%
$37.76$10.3M-29.51%
2022-01-19PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
997,961
2.3789%
$14.10$14.07M-4.25%
2021-11-30PurchaseOlema Pharmaceuticals, Inc.
OLMA
739,675
1.9974%
$9.39$6.95M-52.69%
2021-10-08SaleMerus N.V.
MRUS
10 percent owner
147,267
0.3769%
$27.79$4.09M-9.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.